Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: Case report and literature review

International Journal of Artificial Organs

Volumn 36, Issue 5, 2013, Pages 367-372

  Donato, Maria Francesca ^a   Banfi, Giovanni ^a   Cresseri, Donata ^a   Battista Fogazzi, G ^a   Martin, Paul ^b   Messa, Piergiorgio ^a   Fabrizi, Fabrizio ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis C; Interferon; Liver transplant; Mixed cryoglobulinemia; Ribavirin

Indexed keywords

DISEASES;

ANTIVIRAL THERAPY; CASE REPORTS; HEPATITIS C; HEPATITIS C VIRUS; INTERFERON; LIVER TRANSPLANT; LIVER TRANSPLANTATION; MIXED CRYOGLOBULINEMIA; PEGYLATED; RIBAVIRIN;

VIRUSES;

AMINOTRANSFERASE; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CRYOGLOBULIN; CYCLOSPORIN; DIURETIC AGENT; INSULIN; OMEPRAZOLE; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; CRYOGLOBULINEMIA; DRUG DOSE INCREASE; DRUG TOLERANCE; ERYTHROCYTE CONCENTRATE; FEVER; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOFLUORESCENCE TEST; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; PNEUMONIA; PROTEINURIA;

EID: 84878139794     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000199     Document Type: Article

References (35)

1. Pascual M, Perrin L, Giostra E, Schifer J. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis. 1990;162(2):569-570.
2. Ferri C, Greco F, Longombardo G, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum. 1991;34(12):1606-1610.
3. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992; 327(21):1490-1495.
4. Fabrizi F, Colucci P, Ponticelli C, Locatelli F. Kidney and liver involvement in cryoglobulinemia. Semin Nephrol. 2002; 22(4):309-318.
5. Basse G, Ribes D, Kamar N, et al. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients. Transplantation. 2005;80(11):1560-1564.
6. Rahamimov R, Ilan Y, Eid A, Shouval D, Tur-Kaspa R. Hepatitis C-associated cryoglobulinemia after liver transplantation. Transplantation. 1995;60(9):1050-1051.
7. Abrahamian GA, Cosimi AB, Farrell ML, Schoenfeld DA, Chung RT, Pascual M. Prevalence of hepatitis C virusassociated mixed cryoglobulinemia after liver transplantation. Liver Transpl. 2000;6(2):185-190.
8. Gournay J, Ferrell LD, Roberts JP, Ascher NL, Wright TL, Lake JR. Cryoglobulinemia presenting after liver transplantation. Gastroenterology. 1996;110(1):265-270.
9. Duvoux C, Tran Ngoc A, Intrator L, et al. Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis. Transpl Int. 2002;15(1):3-9.
10. Limaye AP, Schmidt RA, Glenny RW, Davis CL, Kowdley KV. Successful treatment of severe hepatitis C-associated pulmonary vasculitis in a liver transplant recipient. Transplantation. 1998;65(7):998-1000.
11. Sheiner P, Rochon C. Recurrent hepatitis C after liver transplantation. Mt Sinai J Med. 2012;79(2):190-198.
12. Gopal DV, Rabkin JM, Berk BS, et al. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transpl. 2001;7(3):181-190.
13. Davis CL, Gretch DR, Perkins JD, et al. Hepatitis C-associated glomerular disease in liver transplant recipients. Liver Transpl Surg. 1995;1(3):166-175
14. Kendrick EA, McVicar JP, Kowdley KV, et al. Renal disease in hepatitis C-positive liver transplant recipients. Transplantation. 1997;63(9):1287-1293.
15. Sikaneta T, Williams WW, Chung RT, Cosimi AB, Pascual AM. Remission of hepatitis C virus-associated cryoglobulinemic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation. Transplantation. 2002;74(12):1767-1768.
16. Montalbano M, Pasulo L, Sonzogni A, Remuzzi G, Colledan M, Strazzabosco M. Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient. J Clin Gastroenterol. 2007;41(2):216-220.
17. Disease K. Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int. 2008;73(109):S1-S99.
18. Joshi S, Kuczynski M, Heathcote EJ. Symptomatic and virological response to antiviral therapy in hepatitis C associated with extrahepatic complications of cryoglobulimia. Dig Dis Sci. 2007;52(9):2410-2417.
19. Mazzaro C, Monti G, Saccardo F, et al. Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study. Clin Exp Rheumatol. 2011;29(6):933-941.
20. El Khayat H, Fouad Y, Ahmad E, El Amin H, Ismael F, Rizk A. Hepatitis C virus (genotype 4)-associated mixed cryoglobulinemia vasculitis: effects of antiviral treatment. Hepatol Int. 2012;6(3):606-612.
21. Burstein DM, Rodby RA. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. J Am Soc Nephrol. 1993;4(6):1288-1293.
22. Pascual M, Thadhani R, Chung RT, et al. Nephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis. Transplantation. 1997;64(7):1073-1076.
23. Kato T, Sato Y, Yamamoto S, et al. Decreased proteinuria following liver transplantation in a patient with type C liver cirrhosis complicated with nephrotic syndrome: a case report. Transplant Proc. 2004;36(8):2321-2323.
24. Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39(4):1147-1171.
25. Roccatello D, Baldovino S, Rossi D, et al. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia. Clin Rev Allergy Immunol. 2008;34(1):111-117.
26. Ferri C, Cacoub P, Mazzaro C, et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev. 2011;11(1):48-55.
27. De Vita S, Quartuccio L, Isola M, et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 2012;64(3):843-853.
28. Sneller MC, Hu Z, Langford CA. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Arthritis Rheum. 2012;64(3):835-842.
29. Fabrizi F, Martin P, Elli A, et al. Hepatitis C virus infection and rituximab therapy after renal transplantation. Int J Artif Organs. 2007;30(5):445-449.
30. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis. 2008;3:25.
31. Dammacco F, Tucci FA, Lauletta G, et al. Pegylated interferonalpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood. 2010;116(3):343-353.
32. Saadoun D, Resche Rigon M, Sene D, et al. Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferonalpha/ ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood. 2010;116(3):326-334.
33. Fernández I, Ulloa E, Colina F, et al. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C. Liver Transpl. 2009;15(8): 948-955.
34. Fabrizi F, Lunghi G, Dixit V, Martin P. Meta-analysis: antiviral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther. 2006;24(10): 1413-1422.
35. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB; American Association for Study of Liver Diseases. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(4):1433-1444.